Clinical Trials for Nasopharyngeal Cancer

Find clinical trials for nasopharyngeal cancer. Discover research opportunities and treatment options in your area.

18 Active Trials Found

Showing 18 trials on this page

Page 1 of 1

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

NCT ID: NCT04340024

This clinical trial is looking to find specific markers in blood and tissue samples that can help predict how sensitive different cancers are to radiation treatment. It focuses on patients with can...

Recruiting

Type: observational Locations: Singapore, , Singapore

Integrated Cancer Repository for Cancer Research

NCT ID: NCT02012699

The Integrated Cancer Repository for Cancer Research (iCaRe2) is a study designed to gather important information and samples from adults who have been diagnosed with cancer, those at high risk for...

Recruiting

Type: observational Locations: Pittsburgh, Pennsylvania, United States, Denver, Colorado, United States +93 more

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

NCT ID: NCT05983432

This clinical trial is studying a new treatment called BL-B01D1 for patients with metastatic or unresectable non-small cell lung cancer (NSCLC) and other solid tumors, such as certain types of brea...

Recruiting

Phase: PHASE1 Type: interventional Locations: Orange, California, United States, Boston, Massachusetts, United States +43 more

QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

NCT ID: NCT06749899

This clinical trial is studying a new treatment for patients with locoregionally-advanced nasopharyngeal carcinoma (NPC), which is a type of throat cancer. The trial is comparing a drug called QL17...

Recruiting

Phase: PHASE3 Type: interventional Locations: Guangzhou, Guangdong, China, Changsha, Hunan, China +18 more

Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment

NCT ID: NCT04875611

This clinical trial is looking at a treatment called Nivolumab for patients with nasopharyngeal cancer, a type of cancer that affects the area behind the nose and above the throat. Specifically, th...

Recruiting

Phase: PHASE2 Type: interventional Locations: Gliwice, , Poland, Białystok, , Poland +2 more

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

NCT ID: NCT06682442

This clinical trial is studying a new approach to treating nasopharyngeal carcinoma, a type of cancer linked to the Epstein-Barr virus (EBV). The trial compares a method called induction chemothera...

Recruiting

Phase: NA Type: interventional Locations: San Francisco, California, United States

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT ID: NCT06851663

This clinical trial is studying a new imaging technique called Trop2-targeted immunoPET/CT, which aims to help doctors better see and diagnose solid tumors like bladder cancer, prostate cancer, and...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, , China

Adebrelimab and Chemoradiotherapy in High-risk LANPC

NCT ID: NCT06349889

This clinical trial is studying a new treatment approach for patients with high-risk nasopharyngeal carcinoma, a type of cancer that affects the area behind the nose. The researchers are looking at...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China, Chengdu, Sichuan, China +2 more

Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

NCT ID: NCT04925544

This clinical trial is studying a new drug called VK 2019, designed to help patients with certain types of cancer related to the Epstein-Barr Virus (EBV), particularly nasopharyngeal cancer (NPC), ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Stanford, California, United States

Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

NCT ID: NCT06662929

This clinical trial is focused on improving how we understand and measure the experiences of Arabic-speaking patients undergoing radiotherapy for head and neck cancer. The researchers want to valid...

Recruiting

Type: observational Locations: Riyadh, , Saudi Arabia

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

NCT ID: NCT05638269

This clinical trial is studying the gut microbiota, which is the community of bacteria and other microorganisms living in our intestines, in patients with serious chronic diseases like various type...

Recruiting

Type: observational Locations: Nanning, Guangxi, China, Fuzhou, Fujian, China +48 more

Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy

NCT ID: NCT06480903

This clinical trial is looking at how the level of Epstein-Barr Virus (EBV) DNA in the blood changes during radiation therapy for a type of cancer called nasopharyngeal carcinoma, which primarily a...

Not yet recruiting

Type: observational

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

NCT ID: NCT06019130

This clinical trial is studying a treatment for nasopharyngeal carcinoma, a type of cancer that occurs in the area behind the nose. Researchers want to see if adding a medication called Nivolumab, ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Aachen, , Germany, Aachen, , Germany +30 more

The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma

NCT ID: NCT06268600

This clinical trial is focused on protecting the thyroid gland from damage caused by radiation treatment for nasopharyngeal carcinoma, a type of cancer located in the area behind the nose. The rese...

Recruiting

Phase: NA Type: interventional Locations: Nanchang, None Selected, China

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

NCT ID: NCT05628922

This clinical trial is investigating a new treatment approach for patients with locally advanced nasopharyngeal carcinoma (NPC), a type of cancer that affects the area behind the nose and throat. T...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy

NCT ID: NCT04978012

This clinical trial is studying a combination of two medications, Fluzoparib and Camrelizumab, to see how effective and safe they are for treating patients with recurrent or metastatic nasopharynge...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Phase II Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

NCT ID: NCT05305131

This clinical trial is studying a new treatment approach for patients with locally advanced nasopharyngeal cancer, which is a type of cancer that occurs in the area behind the nose. The researchers...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Singapore, , Singapore

Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

NCT ID: NCT04453826

This clinical trial is studying a new treatment approach for patients with high-risk nasopharyngeal carcinoma, a type of cancer that affects the area behind the nose. Researchers want to find out i...

Recruiting

Phase: PHASE3 Type: interventional Locations: Guangzhou, Guangdong, China, Zhuhai, Guangdong, China +4 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions